Rallis India Limited · NSE:RALLIS
Rallis India — Q3 FY22 Earnings Presentation
19 slides from Rallis India's earnings presentation, Jan 19, 2022
Slide 1: Submission of Analysts/Investors Presentation
January 19, 2022 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra-Kurla Complex Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500355 Symbol: RALLIS Dear Sir/Madam, Sub: Submission of Analysts/Investors Presentation Ref: Lett
Slide 2: Q3 FY22 Results Presentation
Q3 FY22 RESULTS PRESENTATION DOMESTIC CROP PROTECTION INTERNATIONAL BUSINESS CONTRACT MANUFACTURING SEEDS PLANT GROWTH NUTRIENTS AGRI SERVICES
Slide 3: Disclaimer
DISCLAIMER This presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expressions or variatio
Slide 4: Our Long Term Strategy Remains on Track
OUR LONG TERM STRATEGY REMAINS ON TRACK CROP CARE (DF/IB/PGN) SEEDS EXTEND PORTFOLIO STRENGTHEN WIDEN REACH PLUG PORTFOLIO OFFERINGS MANUFACTURING GAPS FLEXIBLE MPPS STRONG BD & STRENGTHEN CAPABILITY: MULTIPLE CHEMISTRY DISTRIBUTION PEOPLE & PROCESS SERVING FARMERS THROUGH SCIENCE Note: DF- Domestic
Slide 5: Domestic Crop Protection
DOMESTIC CROP PROTECTION Focused on 3 Comprises of domestic Well Research efforts Identified category, pillars - Extend branded formulations and entrenched focused on segment and portfolio gaps portfolio Institutional connect with developing for future product offerings, business farmers customized
Slide 6: International Business
INTERNATIONAL BUSINESS Manufacturing and Committed to Investment in Expanding Upgrading pilot export of Active expand product strengthening synthesis plants to Ingredients, and customer R&D, process capacity at the strengthen Formulations and portfolio in IBD & scale-up and R&D Centre at process sca
Slide 7: Domestic Crop Nutrition
DOMESTIC CROP NUTRITION Focus on non- Well defined More than Good future potential Robust products subsidized fertilizers product portfolio 1.6x growth to grow given the in pipeline to and crop nutrients - a covering diverse in last 5 years market situation and build stronger niche and growing segme
Slide 8: Seeds Business
SEEDS BUSINESS Rallis is engaged in research, Field Crops: Paddy, This is also We have our focus on development, production, Maize, Pearl Millet, supported through developing high-growth processing and distribution Cotton and Mustard. in-licensing segments across crop categories of hybrid seeds for
Slide 9: Domestic Market Development
DOMESTIC MARKET DEVELOPMENT PRODUCT PROMOTION FARMER ENGAGEMENT CHANNEL ENGAGEMENT Copyright © Rallis India Limited. All rights reserved.
Slide 10: Investing for Future Growth Plans
INVESTING FOR FUTURE GROWTH PLANS CZ Formulation Plant Aceta-Lambda Plant • Metri lines consolidated and commissioned • Formulation plant Phase 1 commissioned. Commercial production started • Two a.i.s plants capacity enhanced and commercial production started at Ankleshwar • MPP at Dahej - There is
Slide 11: Investing for Future Growth Plans
INVESTING FOR FUTURE GROWTH PLANS Dahej Pilot Plant MPP* Progress *Multi Purpose Plant 10
Slide 12: Q3 and YTD Results
Q3 AND YTD RESULTS Q3 FY22 RESULTS PRESENTATION DOMESTIC CROP PROTECTION INTERNATIONAL BUSINESS CONTRACT MANUFACTURING SEEDS PLANT GROWTH NUTRIENTS AGRI SERVICES
Slide 13: Market Situation
MARKET SITUATION • Total rainfall for the season (Oct 1, 2021 to Dec 22, 2021) throughout the country was 175.4mm vs the LPA of 122.8mm recording a 43% increase RAINFALL • Between October 1 and December 11, 68% surplus rainfall has been Oct to Dec ‘21 received by Southern India, leading to spray ski
Slide 14: Financial Snapshot - Q3 & YTD Dec'21
FINANCIAL SNAPSHOT - Q3 & YTD DEC‘21 Rs Crs REVENUE EBITDA PAT 741 725728 92 663 128 122 82 83 628 117 570 88 56 46 60 67 40 Q1 Q2 Q3 Q1 Q2 Q3 Q1 Q2 Q3 FY 21 FY 22 FY 21 FY22 FY 21 FY22 • Growth in both domestic crop care 9% • EBITDA Q3’22 increased by 12%. • Lower export incentive under RODTEP, and
Slide 15: Revenue & Results - Q3 & YTD Dec'21 - Crop Care
REVENUE & RESULTS - Q3 & YTD DEC‘21 - CROP CARE Rs Crs REVENUE EBITDA PAT 703 107108 652 82 600 82 79 74 529 61 471 49 401 45 38 30 23 Q1 Q2 Q3 Q1 Q2 Q3 Q1 Q2 Q3 FY 21 FY22 FY 21 FY22 FY 21 FY 22 • Crop Care revenue growth of 13% for • EBIDTA impacted by inflated RM cost • Lower EBITDA led to lower
Slide 16: Revenue & Results - Q3 & YTD Dec'21 - Seeds
REVENUE & RESULTS - Q3 & YTD DEC‘21 - SEEDS Rs Crs REVENUE EBITDA PAT 60 60 261 269 82 83 -17 -15 -10 73 10 -17 1 41 28 -20 -11 25 Q1 Q2 Q3 Q1 Q2 Q3 Q1 Q2 Q3 FY 21 FY 22 FY 21 FY22 FY 21 FY22 • Seed Industry continues to face • Able to limit loss as compared to PY • PAT reflective of EBITDA trend he
Slide 17: Community Support Activities
COMMUNITY SUPPORT ACTIVITIES Medical O2 plant inaugurated by CM Gujarat virtually @ Urban Community Health Centre, Bhavnagar RUBY (Rallis Ujjwal Bhavishya Yojana) – Educational interventions • English intervention: Identified and trained 2 new community teachers for conducting English intervention •
Slide 18: Corporate Sustainability & Engagement
CORPORATE SUSTAINABILITY & ENGAGEMENT Special Children Physiotherapy under RUBY Project English Tailoring Unit at Skill Intervention Training Center in Mumbai Class at Lote Copyright © Rallis India Limited. All rights reserved.
Slide 19: Thank You
THANK YOU FOR ANY QUERIES PLEASE CONTACT BELOW: Subhra Gourisaria SERVING FARMERS THROUGH SCIENCE subhra.gourisaria@rallis.com Registered Office 23rd Floor, Lodha Excelus, New Cuffe Parade, Gavin Das Off Eastern Freeway, gavin@cdr-india.com Wadala, Mumbai - 400 037 CIN: L36992MH1948PLC014083 Tel. No